Stifel analyst Simon Yarmak lowered his price target on shares of Extended Stay America to $18 from $20.50 after the company reported in line EPS, Q2 RevPAR near the lower-end of guidance and lowered its 2019 RevPAR and EBITDA guidance. The company also disappointed investors by announcing that its board does not view any alternatives as more attractive at this time after conducting a strategic review. He keeps a Buy rating on Extended Stay shares, citing the stock's valuation and the company's continued return of capital through dividends and buybacks.